Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D
NCT: NCT07501338 · NOT_YET_RECRUITING
Brief Summary
Type 1 diabetes is a common chronic medical condition among youth in the US that requires intensive glycemic management to prevent long-term morbidity and mortality. Current pediatric diabetes care in the US underutilizes automated insulin delivery (AID) systems, which are the best available tools for promoting tight glycemic control while reducing user burden. This proposal aims to support early and sustained use of AID systems by examining and optimizing conditions, evaluating glycemic outcomes, and identifying contextual facilitators and barriers of implementation.
Frequently Asked Questions
What is Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D?
Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D is a clinical trial registered under NCT07501338. Current status: NOT_YET_RECRUITING.
What is the status of NCT07501338?
The current status of NCT07501338 (Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D) is: NOT_YET_RECRUITING.
When did Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D start?
Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D started on 2026-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.